Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,093.78
(
-0.22%
)
US TECH 100
25,862.00
(
-0.04%
)
Dow Jones
49,367.43
(
-0.16%
)
Brent Oil
94.23
(
3.92%
)
Bitcoin
75,835.15
(
-0.08%
)
News Focus
News Focus
Post# of 3681
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

skitahoe

Send PM Follow Ignore
Followers 250
Posts 15731
Boards Moderated 1
Alias Born 08/14/2003

skitahoe

Re: north40000 post# 3424

Monday, 01/11/2016 12:04:54 PM

Monday, January 11, 2016 12:04:54 PM

Post# of 3681
Clearly this is bad news, but it is up to what the problem is to determine where Novartis goes from here. They may continue the trial if the safety issues are resolved, or they could try a multi dose trial with lower doses, or they could abandon the drug, at least for now.

I suspect it will take many months, perhaps over a year before we know the direction Novartis is taking.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today